An article published in CAP TODAY highlights Pitt’s efforts to implement pharmacogenomics in a preemptive manor and interviews Phil Empey, Associate Director for Pharmacogenomics at the Institute for Precision Medicine and faculty in the School of Pharmacy and the Clinical and Translational Science Institute, who shares his plans of careful implementation of pharmacogenomic reporting of variants with the highest level of evidence.

Read the article here: